Ikarian Capital, LLC Q1 2020 Filing

Filed May 15, 2020

Portfolio Value

$1.3M

Holdings

115

Report Date

Q1 2020

Filing Type

13F-HR

All Holdings (115 positions)

#	Stock	Shares	Value	% Portfolio	Type
101	—PFENEX INC	64,211	$566K	42.57%
102	KODKODIAK SCIENCES INC	11,800	$563K	42.34%	Put
103	—PROGENICS PHARMACEUTICALS IN	130,845	$497K	37.38%
104	PBYIPUMA BIOTECHNOLOGY INC	54,901	$463K	34.82%
105	—AXOVANT GENE THERAPIES LTD	188,884	$461K	34.67%
106	—BAUDAX BIO INC	175,000	$434K	32.64%
107	MNKMALLINCKRODT PUB LTD CO	194,322	$385K	28.95%
108	CMRXEURCHIMERIX INC	208,258	$300K	22.56%
109	CLLSCELLECTIS S A	30,928	$285K	21.43%
110	—DICERNA PHARMACEUTICALS INC	15,500	$285K	21.43%	Call
111	ARWRARROWHEAD PHARMACEUTICALS IN	7,200	$207K	15.57%	Put
112	—OBSEVA SA	82,573	$199K	14.97%
113	AMRNAMARIN CORP PLC	39,700	$159K	11.96%	Call
114	—AETERNA ZENTARIS INC	117,443	$60K	4.51%
115	—STEALTH BIOTHERAPEUTICS CORP	37,597	$47K	3.53%

PreviousPage 2 of 2